GB Patent

GB9927088D0 — Use of poly(diallylamine) polymers

Assigned to SECR DEFENCE · Expires 2000-01-12 · 26y expired

What this patent protects

A poly(diallylamine)polymer pharmaceutical composition or pharmaceutical derivate used to sequester bile acid and/or to reduce serum cholesterol levels. The polymer is derived from a monomer of formula Ia, where R6 is a bridging group of valency r, and r is an integer of 3 or gre…

USPTO Abstract

A poly(diallylamine)polymer pharmaceutical composition or pharmaceutical derivate used to sequester bile acid and/or to reduce serum cholesterol levels. The polymer is derived from a monomer of formula Ia, where R6 is a bridging group of valency r, and r is an integer of 3 or greater to provide a cross linked polymer, and all diallyl nitrogen atoms are linked to at least two further diallyl nitrogen atoms.

Drugs covered by this patent

Patent Metadata

Patent number
GB9927088D0
Jurisdiction
GB
Classification
—
Expires
2000-01-12
Drug substance claim
No
Drug product claim
No
Assignee
SECR DEFENCE
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.